During the past decade, Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie" are "Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials), "Eczema" (2 trials), "Genetic Diseases, Inborn" (2 trials) and "Hypersensitivity" (2 trials). Many other conditions were trialed in "Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie" in a lesser frequency.

Most popular intervention types in "Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Dupilumab" (1 trials) and "Injectable Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinik und Poliklinik fuer Dermatologie und Venerologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".